Vir Biotechnology Inc (VIR)
9.52
-0.42
(-4.23%)
USD |
NASDAQ |
May 08, 13:10
Vir Biotechnology 1 Year Total Returns (Daily): -59.43% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2024 | -59.43% |
| May 06, 2024 | -58.29% |
| May 03, 2024 | -59.08% |
| May 02, 2024 | -62.71% |
| May 01, 2024 | -65.26% |
| April 30, 2024 | -66.36% |
| April 29, 2024 | -66.72% |
| April 26, 2024 | -66.34% |
| April 25, 2024 | -69.41% |
| April 24, 2024 | -68.35% |
| April 23, 2024 | -68.71% |
| April 22, 2024 | -68.82% |
| April 19, 2024 | -68.33% |
| April 18, 2024 | -68.16% |
| April 17, 2024 | -67.03% |
| April 16, 2024 | -65.95% |
| April 15, 2024 | -65.09% |
| April 12, 2024 | -62.14% |
| April 11, 2024 | -60.70% |
| April 10, 2024 | -61.73% |
| April 09, 2024 | -60.14% |
| April 08, 2024 | -60.31% |
| April 05, 2024 | -59.74% |
| April 04, 2024 | -59.37% |
| April 03, 2024 | -58.38% |
| Date | Value |
|---|---|
| April 02, 2024 | -58.66% |
| April 01, 2024 | -56.17% |
| March 28, 2024 | -55.18% |
| March 27, 2024 | -56.11% |
| March 26, 2024 | -55.67% |
| March 25, 2024 | -55.54% |
| March 22, 2024 | -55.01% |
| March 21, 2024 | -56.19% |
| March 20, 2024 | -57.20% |
| March 19, 2024 | -57.75% |
| March 18, 2024 | -54.88% |
| March 15, 2024 | -54.25% |
| March 14, 2024 | -55.27% |
| March 13, 2024 | -51.44% |
| March 12, 2024 | -52.54% |
| March 11, 2024 | -49.58% |
| March 08, 2024 | -49.87% |
| March 07, 2024 | -50.59% |
| March 06, 2024 | -52.71% |
| March 05, 2024 | -52.36% |
| March 04, 2024 | -51.01% |
| March 01, 2024 | -50.27% |
| February 29, 2024 | -50.70% |
| February 28, 2024 | -49.12% |
| February 27, 2024 | -50.46% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.47%
Minimum
Feb 05 2024
360.5%
Maximum
Feb 17 2021
-2.30%
Average
-22.04%
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals Inc | 17.87% |
| Vistagen Therapeutics Inc | 27.01% |
| Immuneering Corp | -80.45% |
| SeaStar Medical Holding Corp | -76.22% |
| NovaBay Pharmaceuticals Inc | -91.08% |